Evidence map›Paper›PMID 35388376›Full record

ArticleJACS Au2022

Redox Dynamics of Active VO

Anna Zabilska, Adam H Clark, Benjamin M Moskowitz, Israel E Wachs, Yuya Kakiuchi, Christophe Copéret, Maarten Nachtegaal, Oliver Kröcher, Olga V Safonova

Abstract read
In one paragraph

Article in JACS Au, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. TiONature communications · 2026
    Article
  2. 4Journal of the American Chemical Society · 2026
    Article
  3. Hierarchical VONanomaterials (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Intercalant-induced VProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna ZabilskaPaul Scherrer Institute, 5232 Villigen, Switzerland.
Adam H ClarkPaul Scherrer Institute, 5232 Villigen, Switzerland.ORCID https://orcid.org/0000-0002-5478-9639
Benjamin M MoskowitzOperando Molecular Spectroscopy & Catalysis Laboratory, Department of Chemical & Biomolecular Engineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
Israel E WachsOperando Molecular Spectroscopy & Catalysis Laboratory, Department of Chemical & Biomolecular Engineering, Lehigh University, Bethlehem, Pennsylvania 18015, United States.ORCID https://orcid.org/0000-0001-5282-128X
Yuya KakiuchiDepartment of Chemistry and Applied Biosciences, ETH Zürich, CH-8093 Zürich, Switzerland.
Christophe CopéretDepartment of Chemistry and Applied Biosciences, ETH Zürich, CH-8093 Zürich, Switzerland.ORCID https://orcid.org/0000-0001-9660-3890
Maarten NachtegaalPaul Scherrer Institute, 5232 Villigen, Switzerland.ORCID https://orcid.org/0000-0003-1895-9626
Oliver KröcherPaul Scherrer Institute, 5232 Villigen, Switzerland.ORCID https://orcid.org/0000-0002-7268-7257
Olga V SafonovaPaul Scherrer Institute, 5232 Villigen, Switzerland.ORCID https://orcid.org/0000-0002-6772-1414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Titania-supported vanadia (VO

Identifiers

PMID35388376
PMCPMC8977985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.